Abstract
This chapter is concerned with the pharmacology of agents that are used therapeutically for the treatment of a variety of disorders including anxiety, sleep, and psychosomatic disorders, and for sedation, skeletal muscle relaxation, and for the treatment of epilepsy. The distinct classification of these agents as sedatives, hypnotics, and anxiolytics is clouded since they have overlapping pharmacologie activities. For example, some agents, particularly certain benzodiazepines, can be used therapeutically either to treat the aforementioned conditions or achieve the effects mentioned to one degree or another. The drugs that are discussed include the benzodiazepines (full and partial agonists, full and partial inverse agonists, and antagonists), buspirone, zolpidem, selected barbiturates, and other sedative-hypnotics of diverse chemical structures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbruzzese, A., & Swanson, J. (1965). Jaundice after therapy with chlordiazepoxide hydrochloride.New England Journal of Medicine.273, 321–322.
Amin, J., & Weiss, D. S. (1993). GABA, receptor needs two homologous domains of the (3-subunit for activation by GABA but not by pentobarbital.Nature,366, 565–569.
Andersson, L. C., Lehto, V. P., Stenman, S., Badley, R. A., & Virtanen, I. (1981). Diazepam induces mitotic arrest at prometaphase by inhibiting centriolar separation.Nature,291, 247–248.
Andrada-Martinez, R., Marquez-Orozco, M. C., & Marquez-Orozco, A. (1993). Cerebellar histological changes produced by diazepam.Proceedings of the Western Pharmacology Society,36, 219–225.
Arbilla, S., Depoortere, H., George, P., & Langer, S. Z. (1985). Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats.Archives of Pharmacology,330, 248–251.
Ashton, H. (1984). Benzodiazepine withdrawal: An unfinished story.British Medical Journal.288, 1135–1140.
Bakti, G., Fisch, H. U., Karlaganis, G., Minder, C., & Bircher, J. (1987). Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: Model experiments with triazolam.Hepatology,7, 629–638.
Barnas, C., Whitworth, A. B., & Fleischhacker, W. W. (1993). Are patterns of benzodiazepines use predictable?Psychopharmacology,111, 301–305.
Basile, A. S., Jones, E. A., & Skolnick, P. (1991). The pathogenesis and treatment of hepatic encephalopathy: Evidence for the involovement of benzodiazepine receptor ligands.Pharmacological Reviews,43, 27–71.
Bell, J. A., & Anderson E. G. (1972). The influence of semicarbazide-induced depletion of y-aminobutyric acid on presynaptic inhibition.Brain Research 43, 161 - 169.
Bianchi, G., & Steiner, P. (1992). A clinical double-blind study of flumazenil, antagonist of benzodiazepines in loco-regional anesthesia.Acta Anesthesthesiologica Belgica,43, 121–129.
Bitran, D., Primus, R. J., & Kellogg, C. K. (1991). Gestational exposure to diazepam increases sensitivity to convulsants that act at the GABA/benzodiazepine receptor complex.European Journal of Pharmacology,196, 223–231.
Boisse, N. R., & Okamoto, M. (1978a). Physical dependence to barbital compared to pentobarbital “Chronically equivalent” dosing method.Journal of Pharmacology and Experimental Therapeutics,204, 497–506.
Boisse, N. R., & Okamoto, M. (1978b). Physical dependence to barbital compared to pentobarbital: IV. Influence of elimination kinetics.Journal of Pharmacology and Experimental Therapeutics,204, 526–540.
Bourguignon, J. (1993). Endogenous and synthetic ligands of mitochondria) benzodiazepine receptors: Structure-affinity relationships. In E. Geisen-Crouse (Ed.),Peripheral benzodiazepine receptors(pp. 59–82 ). New York: Academic Press.
Braestrup, C. (1981). Biochemical effects of anxiolytics. In F. Hoffmeister, G. Stille (Eds.),Handbook of experimental pharmacology(Vol. 55/II, pp. 293–319 ). Berlin: Springer-Verlag.
Branch, R. A., Morgan, M. H., Jones, J., & Read, A. E. (1976). Intravenous administration of diazepam in patients with chronic liver disease.Gut,17, 975–983.
Briemer, L. T. M., Burm, A. G. L., Danhof, M., Hennis, P. J., Vletter, A. A., de Voogt, J. H., Spierdijk, J., & Bovill, J. G. (1991). Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEGanalysis. Clinical Pharmacokinetics,22(6), 497–508.
Bucher, J. R., Shackelford, C. C., Haseman, J. K., Johnson, J. D., Kurtz, P. J., & Persing, R. L. (1994). Carcinogenicity studies of oxazepam in mice.Fundamental and Applied Toxicology,23, 280–297.
Buchsbaum, M. S., Hazlett, E., Sicotte, N., Stein, M., Wu, J., & Zetin, M. (1985). Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder.Biological Psychiatry,20, 832–842.
Byrnes, J. J., & Miller, L. G. (1993). Prenatal benzodiazepine exposure: Ill. Lorazepam exposure is associated with a shift toward inverse agonist efficacy.Journal of Psychopharmacology,7, 39–42.
Cacioppo, J., & Merlis, S. (1961). Chlordiazepoxide hydrochloride (librium) and jaundice: Report of a case.American Journal of Psychiatry,117, 1040–1041.
Cadranel, J. E, Younsi, M. E., Pidoux, B., Zylberberg, P., Benhamou, Y., Valla, D., & Opolon, P. (1995). Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: A double-blind pragmatic randomized, placebo study.European Journal of Gastroenterology and Hepatology,7, 325–329.
Calvo, D. J., & Medina, J. H. (1992). Regulation of peripheral-type benzodiazepine receptors following repeated benzodiazepine administration.Functional Neurology, 7, 227–230.
Chesley, S., Lumpkin, M., Schatzki, A., Galpern, W. R., Greenblatt, D. J., Shader, R. I., & Miller, L. G. (1991). Prenatal exposure to benzodiazepine: I. Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function.Neuropharmacology,30, 53–58.
Chiu, T. H., Tietz, E. 1., & Rosenberg, H. C. (1987). Benzodiazepines. In I. K. Ho (Ed.),Toxicology of CNS depressants(pp. I-32). Boca Raton, FL: CRC.
Chiu, T. H., & Rosenberg, H. C. (1995). Barbiturates and benzodiazepines: Effects and mechanisms. In L. W. Chang & R. S. Dyer (Eds),Handbook of neurotoxicology(pp. 739–767 ). New York: Dekker.
Cittadini, A., & Lader, M. (1991). Lack of effect of a small dose of flumazenil in reversing short-term tolerance to benzodiazepines in normal subjects.Journal of Psychopharmacology, 5, 220–227.
Cobden, 1., Record, C. O., & White, R. W. B. (1981). Fatal interhepatic choleostasis associated with triazolam.Postgraduate Medical Journal,57, 730–731.
Cunningham, M. L. (1965). Acute hepatic necrosis following treatment with amitriptyline and diazepam.American Journal of Psychiatry,111, 1107–1109.
Curtis, D. R., Duggan, A. W, Felix D., & Johnston, G. A. R. (1971). Bicuculline, an antagonist of GAGA and synaptic inhibition in the spinal cord.Brain Research,32, 69–96.
De la Iglesia, A., Barsoum, N., Gough, A., Mitchell, L., Martin, R. A., di Fonzo, C., & McGuire, E. J. (1981). Carcinogenesis bioassay of prazepam (Verstran) in rats and mice.Toxicology Applied Pharmacology,57, 39–54.
Dennis, T., Dubois, A., Benavides, J., & Scatton, B. (1988). Distribution of central co, (Benzodiazepine,) and wZ (Benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [’H]Flunitrazepam and the w, selective ligand [3H]Zolpidem.Journal of Pharmacology and Experimental Therapy,247, 309–322.
Derlet, R. W, & Albertson, T. E. (1994). Flumazenil induces seizures and death in mixed cocaine-diazepam intoxications.Annals of Emergency Medicine,23, 494–498.
de Wit, H., & Griffiths, R. R. (1991). Testing the abuse liability of anxiolytic and hypnotic drugs in humans.Drug and Alcohol Dependence,28, 83–111.
Diana, G., & Massotti, M. (1992). Repeated administration of diazepam reduces [3H]Ro 5–4864 binding in cerebral cortex of rats.Pharmacology,Biochemistry and Behavior,42, 297–300.
Dimpfel, W., Spüler, M., Nickel, B. (1986). Radioelectroencephalography (tele-stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital.Neuropsychobiology,16, 163–168.
Doble, A., & Martin, I. L. (1992). Multiple benzodiazepine receptors: No reason for anxiety.TiPS,13, 76–78.
Doble, A., Malgouris, C., Daniel, M., Daniel, N., Imbault, E, Basbaum, A., Uzan, A., Guérémy, C., & Le Fur, G. (1987). Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution.Brain Research Bulletin,18, 49–61.
Domino, E. F., French, J., Pohorecki, R., Galus, C. E, & Pandit, S. K. (1989). Further observations on the effects of subhypnotic doses of midazolam in normal volunteers.Psychopharmacology,25, 460–465.
Essig, C. F. (1967). Clinical and experimental aspects of barbiturate withdrawal convulsions.Epilepsia,8, 21–30.
Evans, S. M., Funderburk, F. R., & Griffiths, R. R. (1990). Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability.Journal of Pharmacology and Experimental Therapeutics,255, 1246–1255.
Fialip, J., Aumaitre, O., Eschalier, A., Maradeix, B., Dordain, G., & Lavarenne, J. (1987). Benzodiazepine withdrawal seizures: Analysis of 48 case reports.Clinical Neuropharmacologv,6, 536–544.
File, S. E. (1990). The history of benzodiazepine dependence: A review of animal studies.Neuroscience and Biohehavioral Review,14, 135–146.
File, S. E., & Baldwin, H. A. (1989). Changes in anxiety in rats tolerant to, and withdrawn from, benzodiazepines: Behavioural and biochemical studies. In R Tyrer, (Ed.),Psychopharmacology of anxiety(pp. 28–51 ). Oxford, England: Oxford University Press.
File, S. E., & Pellow, S. (1986). Intrinsic actions of the benzodiazepine receptor antagonist Ro 15–1788.Psychopharmacology,88, 1–11.
Fink, M., Irwin, P., Weinfeld, R. E., Schwartz, M. A., & Conney, A. H., (1976). Blood levels and electroencephalographic effects of diazepam and bromazepam.Clinical Pharmacology Therapeutics,20, 184–191.
Fox, K. A., & Lahcen, R. B. (1974). Liver-cell adenomas and peliosis hepatis in mice associated with oxazepam.Research Communications in Chemical Pathology and Pharmacology,8, 481–488.
Friedman, H., Greenblatt, D. J., Peters, G. R., Metzler, C. M., Charlton, M. D., Harmatz, J. S., Antal, E. J., Sanborn, E. C., & Francom, S. F. (1992). Pharmacokinetics and pharmacodynamics of oral diazepam: Effects of dose, plasma concentration, and time.Clinical Pharmacology Therapeutics,52, 139–150.
Gallager, D. W., & Primus, R. J. (1993). Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change. In S. Wonnacott & G. Glunt (Eds.),Neurochemistry of drug dependence(pp. 135–151 ). London: Portland.
Gallager, D. W., Heninger, K., & Heninger, G. (1986). Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates.European Journal of Pharmacology 132, 31 - 38.
Gallager, D. W., Jacobs, A. A., Crais, J. S., During, M. J., & Hernandez, T. D. (1991). Chronic treatments that produce reversible and irreversible changes in gamma-aminobutyric acid sensitivity. In E. A. Bernard & E. Costa (Eds.),Transmitter amino acid receptors,structures,transactions and model(pp. 113–128 ). New York: Raven.
Gallager, D. W, Marley, R. J., & Hernandez, T. D. (1991). Biochemical and electrophysiological mechanisms underlying benzodiazepine tolerance and dependence. In J. Pratt (Ed.),The biological bases of drug tolerance and dependence(pp. 49–70 ). London: Academic Press.
Gardner, C. R., Tully, W. R., & Hedgecock, C. J. R. (1993). The rapidly expanding range of neuronal benzodiazepine receptor ligands.Progress in Neurobiology 40, 1 - 61.
Gavish, M., Bar-Ami, S., & Weitzman, R. (1992). The endocrine system and mitochondrial benzodiazepine receptors.Molecular and Cellular Endocrinology 88, 1 - 13.
Gavish, M., Bar-Ami, S., & Weitzman, R. (1993). Pathophysiological and endocrinological aspects of peripheral-type benzodiazepine receptors. In E. Giesen-Crouse (Ed.),Peripheral benzodiazepine receptors(pp. 210227 ). London: Academic Press.
Glaser, G. H., Penry, J. K., & Woodbury, D. M. (1980).Antiepileptic drugs: Mechanisms of action. New York: Raven.
Gonsalves, S. F., & Gallager, D. W. (1988). Persistent reversal of tolerance to anticonvulsant effects and GABAergic subsensitivity by a single exposure to benzodiazepine antagonist during chronic benzodiazepine administration.Journal of Pharmacology and Experimental Therapy,244, 79–83.
Grant, S. J., Galloway, M. P., Mayor, R., Fenerty. J. R, Finkelstein, M. F., Roth, R. H., & Redmond, D. E. Jr. (1985). Precipitated diazepam withdrawal elevates noradrenergic metabolism in primate brain.European Journal of Pharmacology,107, 127–132.
Greenblatt, D. J., Shader, R. I. (1985). Clinical pharmacokinetics of the benzodiazepines. In D. E. Smith & D. R. Wesson (Eds.),The benzodiazepines: Current standards for medical practice(pp. 43–64 ). Lancaster, England: MTP.
Griffiths, R. R. (1995). Commentary on review by Woods and Winger. Benzodiazepines: Long-term use among patients is a concern and abuse among polydrug abusers is not trivial [Letter to the editor].Psvchopharmacology,118, 116–117.
Griffiths, R. R., & Wolf, B. (1990). Relative abuse liability of different benzodiazepines in drug abusers.Journal of Clinical Psychopharmacology,10(4), 237–243.
Haefely, W. E. (1977). Synaptic pharmacology of barbiturates and benzodiazepines.Agents Actions,7, 353–359.
Haefely, W. (1986). Biological basis of drug induces tolerance, rebound, and dependence. Contribution of recent research on benzodiazepines.Pharmacopsychiatria(Stuttgart),19, 353–361.
Haefely, W. E. (1990). The GABAA-benzodiazepine receptor: Biology and pharmacology. In G. D. Brown, M. Ruth, & R. Noyer (Eds.),Handbook of anxiety: Vol. 3 The neurobiology of anxiety(pp. 165–188 ). Amsterdam: Elsevier.
Haefely, W, Kyburz, E., Gerecke, M., & Möhler, H. (1985). Recent advances in the molecular pharmacology of benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists. In B.Testa (Ed.),Advances in drug research(Vol. 14, pp. I65–322 ). London: Academic Press.
Haefely, W. Martin, J. R., & Schoch, P. (1990). Novel anxiolytics that act as partial agonists at benzodiazepine receptors.TiPS,11, 452–456.
Hallstrom, C., & Lader, M. (1981). Benzodiazepine withdrawal phenomena.International Pharmacopsychiatry,16, 235–244.
Herings, R. M. C., Stricker, B. H.. de Boer, A., Bakker, A., & Sturmans, E. (1995). Benzodiazepines and the risk of falling leading to femur fractures.Archives of Internal Medicine,155, 1801–1807.
Hernandez-Alvarez, L. A. I., Marquez-Orozco, M. C., Marquez-Orozco, A., & Hicks, J. J. (1991). Efectos teratolbgicos de las benzodiazepinas.Ginecologia y Obstetricia de Mexico,59, 195–201.
Hernandez-Alvarez, L. A. I., Marquez-Orozco, M. C., & Marquez-Orozco, A. (1994). Mating behavior of female mice treated prenatally with diazepam.Proceedings of the Western Pharmacology Society,37, 69–71.
Herrmann, W. M., & Schaerer, E. (1986). Pharmaco-EEG: Computer EEG analysis to describe the projection of drug effects on a functional cerebral level in humans. In F. H. Lopes da Silva, W. Storm van Leevwen, & A. Redmond (Eds.),Handbook ofelectroencephalography and clinical neurophvsiolog: Vol. 2. Clinical applications of computer analysis of EEG and other neurophysiological signals(pp. 385–445 ). Amsterdam: Elsevier.
Hertz, L. (1993). Binding characteristics of the receptor and coupling to transport proteins. In E. GiesenCrouse (Ed.),Peripheral benzodiazepine receptors(pp. 27–57 ). London: Academic Press.
Hines, L. R. (1981). Toxicology and side-effects of anxiolytics. In F. Hoffmeister & G. Stille (Eds.),Handbook of experimental pharmacology(Vol. 55/II, pp. 359–393 ). Berlin: Springer-Verlag.
Ho, I. K. (1987). Barbiturate sedative-hypnotics. In I. K. Ho (Ed.),Toxicology of CNS depressants(pp. 33–55 ). Boca Raton, FL: CRC.
Ho, I. K., & Harris, R. A. (1981). Mechanism of action of barbiturates.Annual Review of Pharmacology and Toxicology,21, 83–111.
Hobbs, W. R., Rall, T. W, & Verdoorn, T. A. (1996). Hypnotic, and sedatives; Ethanol. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, & A. Goodman Gillman (Eds.),Goodman Gilntans the pharmacological basis of therapeutics(pp. 361–430 ). New York: McGraw-Hill.
Hollister, L. E. (1985). Principles of therapeutic applications of benzodiazepines. In D. E. Smith & D. R. Wesson (Eds.),The benzodiazepines current standards for medical practice(pp. 87–96 ). Lancaster, England: MTP.
Hollister, L. E., & Csernansky, J. G. (1990).Clinical pharmacology of psychotherapeutic drugs( 3rd ed. ). New York: Churchill Livingstone.
Hollister, L. E., Muller-Oerlinghausen, B., Rickels, K., & Shader, R. I. (1993). Clinical uses of benzodiazepines.Journal of Clinical Psvchopharmacology,13, 1–169.
Hunkeler, W, Möhler, H., Pieri, L., Polc. P. Bonetti, E. P, Cumin-Schaffner, R., & Haefely, W. (1981). Selective antagonists of benzodiazepines.Nature,290, 514–516.
Iguchi, M. Y., Handelsman, L., Bickel, W. K., & Griffiths, R. R. (1993). Benzodiazepine and sedative use/abuse by methadone maintenance clients.Drug and Alcohol Dependence,32, 257–266.
Isbell, H.. & Fraser, H. F., (1950). Addiction to analgesics and barbiturates.Journal of Pharmacology and Experimental Therapeutics,99, 355–397.
Iwaya, N., Morita, Y., & Miyoshi, K. (1989). Determination of pharmoco-dynamics of diazepam by quantitative pharmaco-EEG.Japanese Journal of Psychiatry and Neurology,43, 675–684.
Jaffe, J. H., Ciraulo, D. A., Nies, A., Dixon, R. B., & Monroe, L. L. (1983). Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal.Clinical Pharmacology Therapeutics,34, 623–630.
Judd, F. K., Norman, T. R., Marriott, P. F., & Burrows, G. D. (1986). A case of alprazolam-related hepatitis.American Journal of Psychiatry,143. 388–389.
Judd, F. K., Norman, T. R., & Burrows, G. D. (1990). Pharmacotherapy of panic disorder.International Review of Psychiatry,2, 399–409.
Juergens, S. M. (1993). Benzodiazepines and addiction.Psychiatric Clinics of North America,16, 75–86.
Kay, D. C., Blackburn, A. B., Buckingham, J. A., & Kara-can, I. (1976). Human pharmacology of sleep. In R. L. Williams & I. Karacan (Eds.),Pharmacology of sleep(pp. 83–210 ). New York: Wiley.
Kellogg, C. K., Taylor, M. K., Rodriguez-Zafra, M., & Pleger, G. L. (1993). Altered stressor-induced changes in GABAA receptor function in the cerebral cortex of adult rats exposed in utero to diazepam.Pharmacology,Biochemistry and Behavior,44, 267–273.
King, M. B., Gabe, J., Williams, P., & Rodrigo, E. K. (1990). Long term use of benzodiazepines: The views of patients.British Journal of General Practice,40, 194–196.
Kinoshita, T., Michel, C. M., Yagyu, T., Lehmann, D., & Saito, M. (1994). Diazepam and sulpiride effects on frequency domain EEG source locations.Neuropsychobiology,30, 126–131.
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C., & Beer, B. (1979). Resolution of two biochemically and pharmacologically distinct benzodiazepine receptors.Pharmacology,Biochemistry and behavior; 11, 457 – 462.
Koff J. M., & Miller, L. G. (1995). Prenatal lorazepam exposure: 4. Persistent alterations in pentylenetetrazoleinduced seizure threshhold and GABA-dependent chloride uptake after prenatal lorazepam exposure.Pharmacology,Biochemistry and Behavior,51, 721–724.
Krueger, K. E., & Papadopoulos, V. (1993). The role of mitochondria) benzodiazepine receptors in steriodogenesis. In E. Giesen-Crouse (Ed.),Peripheral benzodiazepine receptors(pp. 89–109 ). London: Academic Press.
Lader, M. (1995). Commentary on review by Woods and Winger entitled “Current benzodiazepine issues” [Letter to the editor].Psychopharmacology,118, 118.
Ladewig, D. (1984). Dependence liability of the benzodiazepines.Drug and Alcohol Dependence,13, 139–149.
Laegreid, L., Olegard, R., Wahlstrom, J., & Conradi, N. (1989). Teratogenic effects of benzodiazepine use during pregnancy.Journal of Pediatrics,114, 126–131.
Lamb, R. J., & Griffiths, R. R. (1985). Effects of repeated Ro 15–1788 administration in benzodiazepine-dependentbaboons. European Journal of Pharmacology,110, 257–261.
Langtry, H. D., & Benfield, P. (1990). Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential.Drugs,40, 291–313.
Levitan, E. S., Schofield, P. R., Burt, D. R., Rhee, L. M., Wisen, W., Kohler, M., Fujita, N., Rodriguez, H. F., Stephenson, A., Darlison, M. G., Barnard, E. A., & Seeburg, P. H. (1988). Structural and functional basis for GABA,A receptor heterogeneity.Nature(London), 335, 76–70.
Livezey, G. T., Radulovacki, M., Isaac, L., Marczynski, T. J. (1985). Prenatal exposure to diazepam results in enduring reductions in brain receptors and deep slow wave sleep.Brain Research,334, 361–365.
Lo, K. J., Eastwood, I. R., & Eidelman, S. (1967). Cholestatic jaundice associated with chlordiazepoxide hydrochloride (librium).American Journal of Digest Diseases,12, 845–849.
Longo, V. G., Massotti, M., DeMedici, D., & Valerio, A. (1988). Modifications of brain electrical activity after activation of the benzodiazepine receptor types in rats andrabbits. Pharmacology,Biochemistry and Behavior,29, 785–790.
Löscher, W., & Rundfeldt, C. (1989). Intermittent flumazenil and benzodiazepine tolerance: Discouraging findings in rats.Lancet,1, 1386.
Lukas, S. E., & Griffiths, R. R. (1984). Precipitated diazepam withdrawal in baboons: Effects of dose and duration of diazepam exposure.European Journal of Pharmacology,100, 163–171.
Macdonald, R. L., & McLean, M. J. (1986). Anticonvulsant drugs: Mechanisms of action.Advances in Neurology.44, 713–736.
Mandema, J. W., & Danhof, M. (1992). Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.Clinical Pharmacokinetics,23, 191–215.
Mandema, J. W., Sansom, L. N., Dios-Vièitez, M. C., Hollander-Jansen, M., & Danhof, M. (1991). Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.Journal of Pharmacology and Experimental Therapeutics,257, 472–478.
Mandema, J. W., Kuck, M. T., & Danhof, M. (1992a). Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.British Journal of Pharmacology,105, 164–170.
Mandema, J. W., Kuck, M. T., & Danhof, M. (1992b). In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.Journal of Pharmacology and Experimental Therapeutics,26, 56–61.
Mandema, J. W., Tukker, E., & Danhof, M. (1992). In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: Midazolam and flumazenil.Journal of Pharmacology and Experimental Therapeutics,260, 36–44.
Manmaru, S., & Matsuura, M., (1990). Two kinds of spatiotemporal EEG changes after discontinuation of benzodiazepine, medazepam.Japanese Journal of Psychiatry and Neurology,44, 85–90.
Marquez-Orozco, A., Marquez-Orozco, M. C., & GazcaRamirez, M. V. (1993). Histological changes in the tibia of the mouse fetus exposed to diazepam.Proceedings of the Western Pharmacology Societu,36, 107–112.
Marquez-Orozco, A., Hernandez-Alvarez, L. A. I., & Marquez-Orozco, M. C. (1994). Sexual activity in male mice treated prenatally with diazepam.Proceedings of the Western Pharmacology Society, 37, 65–68.
Marquez-Orozco, M. C., Marquez-Orozco, A., & GazcaRamirez, M. V. (1993). Effects of diazepam on the ultrastructure of fetal mice hepatocytes.Proceedings of the Western Pharmacology Society,36, 113–116.
Martin, J. R., & Haefely, W. E. (1995). Drugs used for the treatment of anxiety and sleep disorders. In P. L. Munson, R. A. Mueller, & G. R. Briese, (Eds.),Principles of pharmacology,basic concepts clinical practice(pp. 243–277 ). New York: Chapman & Hall.
Martin, J. R., Moreau, J. L., & Jenck, F. (1995). Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam.Psychopharmacology,118, 273–279.
Martin, W. R., Sloan, J. W., & Wala, E. (1990). Precipitated abstinence in orally dosed benzodiazepinedependent dogs.Journal of Pharmacology and Experimental Therapeutics,255, 744–755.
Martin, W. R., Sloan, J. W., & Wala, E. P. (1993). Precipitated abstinence in the diazepam-dependent rat.Pharmacology,Biochemistry and Behavior,46, 683–688.
Martinez, J. A., Fargeas, M. J., & Bueno, L. (1992). Physical dependence on diazepam: Precipitation of abstinence syndromes by peripheral and central benzodiazepine receptor antagonists.Pharmacology,Biochemistry and Behavior,41, 461–464.
Massotti, M., Mele, L., & De Luca, C. (1990). Involvement of the “peripheral” benzodiazepine receptor type (ws) in the tolerance to the electroencephalographic effects of benzodiazepines in rats: Comparison of diazepam and clonazepam.Pharmacology. Biochemistry and Behavior,35, 933–936.
Mata-Santibanez, M. V., Marquez-Orozco, M. C., & Marquez-Orozco, A. (1993). Testicular histological changes in-mice after prenatal administration of diazepam.Proceedings of the Western Pharmacology Society,36, 177–121.
Medina, J. H., Novas, M. L., & de Robertis, E. (1983). Chronic Ro 15–1788 treatment increases the number of benzodiazepine receptors in rat cerebral cortex and hippocampus.European Journal of Pharmacology,90, 125–128.
Mele, L., Sagratella, S., & Massotti, M. (1984). Chronic administration of diazepam to rats causes changes in EEG patterns and in coupling between GABA receptors and benzodiazepine binding sites in vitro.Brain Research,323, 93–102.
Mendelson, W. B. (1992). Neuropharmacology of sleep induction by benzodiazepines.Critical Reviews in Neurobiology,6, 221–232.
Mendelson, W. B., Gillin, J. C., & Wyatt, R. J. (1977).Human sleep and its disorders. New York: Plenum.
Miller, L G., & Koff, J. M. (1994). Interaction of central and peripheral benzodiazepine sites in benzodiazepine tolerance and discontinuation.Progress in Neuro-Ps.vchophu•maco[ogv Biological Psychiatry. 18, 847 - 857.
Miller, L. G., Greenblatt, D. J., Lopez, F., Schatzki, A., Heller, J., Lumpkin, M., & Shader, R. I. (1990). Chronic benzodiazepine administration: Effectsin vivoandin vitro. In G. Biggio & E. Costa (Eds.),GABA and benzodiazepine receptor subtypes(pp. 167–175 ). New York: Raven.
Morrow, A. L., Pace, J. R., Purdy, R. H., & Paul, S. M. (1990). Characterization of steriod interactions with GABA receptor-gated chloride ion channels.Molecular Pharmacology,37. 262–270.
National Institute on Drug Abuse. (1994a).Data from the Drug Abuse Warning Network (DAWN): Annual emergency room data 1992(NIDA Statistical Series I, No. 12-A, p. 37). Rockville, MD: Author.
National Institute on Drug Abuse. (19946).Data from the Drug Abuse Warning Network (DAWN): Annual medical examiner data 1992 (NIDA Statistical Series I, No. 12-B, p. 21). Rockville, MD: Author.
Nicoll, R. A. (1980). Sedative-hypnotics: Animal pharmacology. In L. L. Iversen, S. D. Iversen, & S. H. Snyder (Eds.),Handbook of psychopharmacology: Vol. 12. Drugs of abuse(pp. 187–234 ). New York: Plenum.
Niddam, R., Dubois, A., Scatton, B., Arbilla, S., & Langer, S. Z. (1987). Autoradiographic localization of [3H]Zolpidem binding sites in the rat CNS: Comparison with the distribution of [3H]Flunitrazepam binding sites.Journal of Neurochemistry.49, 890–899.
Norenberg, M. D., & Bender, A. S. (1994). Astrocyte swelling in liver failure: Role of glutamine and benzodiazepines.Acta Neurochirurgica 60, (Suppl.), 24 - 27.
Ober, K. (1974). Effects of diazepam on cell division rates and productivity ofSeenedesmus ohliguusin synchronous cultures.Archives of Microbiology,99, 369–378.
Okamoto, M. (1978). Barbiturates and alcohol: Comparative overviews on neurophysiology and neurochemistry. In M. A. Lipton, A. DiMascio, & K. F. Killam (Eds.),Psychopharmacology: A generation of progress(pp. 1575–1590 ). New York: Raven.
Persohn, E., Malherbe, P., & Richards, J. G. (1992). Comparative molecular neuroanatomy of cloned GABA, receptor subunits in the rat CNS.Journal of Comparative Neurology,326, 193–216.
Pétursson, H. (1994). The benzodiazepine withdrawal syndrome.Addiction,89, 1455–1459.
Pétursson, H., & Lader, M. H. (1981). Withdrawal from long-term benzodiazepine treatment.British Medical Journal,283, 643–645.
Pole, P. (1988). Electrophysiology of benzodiazepine receptor ligands: Multiple mechanisms and sites of action.Progress in Neurobiology,31, 349–423.
Primus, R. J., & Gallager, D. W. (1992). GABA, receptor subunit mRNA levels are differentially influenced by chronic FG 7142 and diazepam exposure.European Journal of Pharmacology-Molecular Pharmacology Section,226, 21–28.
Primus, R. J., Yu, J., Xu, J., Hartnett, M., Meyyappan, M., Kostas, C., Ramabhadran, T. V, & Gallager, D. W. (1996). Allosteric uncoupling after chronic benzodiazepine exposure of recombinant y-aminobutyric acids receptors expressed in Sf9 cells: Ligand efficacy and subtype selectivity.Journal of Pharmacology and Experimental Therapeutics.276, 882–890.
Pritchett, D. B.. Sontheimer, H.. Gorman, C. M., Kettenmann, H., Seeburg, P. H., & Schofield, P. R. (1988). Transient expression shows ligand gating and allostericpotentiation of GABA. receptor subunits.Science(Washington, DC),242, 1306–1308.
Regan, C. M., Gorman, A. M. C., Larsson, O. M., Maguire, C., Martin, M. L., Schousboe, A., & Williams, D. C. (1990).In vitro screening for anticonvulsant-induced teratogenesis in neural primary cultures and cell lines.International Journal of Developmental Neuroscience,8, 143–150.
Rementeria, J. L., & Bhatt, K. (1977). Withdrawal symptoms in neonates from intrauterine exposure to diazepam.Journal of Pediatrics,90, 123–126.
Richards, G., Möhler, H., & Haefely, W. (1986). Mapping benzodiazepine receptors in the CNS by radiohistochemistry and immunohistochemistry. In P. Panula, H. Paivarinta, & S. Soinila (Eds.),Neurohistochemistry: Modern methods and applications(pp. 629–677 ). New York: Liss.
Richter, J. A., & Holtman, J. R., Jr. (1982). Barbiturates: Their in vivo effects and potential biochemical mechanisms.Progress in Neurobiology,18, 275–319.
Rickels, K., Schweizer, E., Case, W. G., & Greenblatt, D. J. (1991). Long term therapeutic use of benzodiazepines: I. Effects of abrupt discontinuation.Archives of General Psychiatry,47, 899–907.
Robinson, R. L., Van Ryzin, R. J., Stoll, R. E., Jensen, R. D., & Bagdon, R. E. (1984). Chronic toxicity/carcinogenesis study of temazepam in mice and rats.Fundamentals and Applied Toxicology,4, 394–405.
Romach, M. K., Busto, U. E., Sobell, L. C., Sobell, M. B., Somer, M. A., & Sellers, E. M. (1991). Long-term alprazolam use: Abuse, dependence or treatment.Psychopharmacology Bulletin,27, 391–395.
Rosenberg, H. C. (1995). Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment.Pharmacology,Biochemistry and Behavior,51, 363–368.
Rosenberg, H. C., & Chiu, T. H. (1982). An antagonist-induced benzodiazepine abstinence syndrome.European Journal of Pharmacology,81, 153–157.
Roy-Byrne, P., Vittone, B. J., & Uhde, T. W. (1983). Alpra- zolam-related hepatotoxicity.Lancet,2, 786–787.
Saano, V. (1993). Effects of peripherally acting benzodiazepines on cell growth and differentiation. In E. Giesen-Crouse (Ed.),Peripheral benzodiazepine receptors(pp. 1 I I-124). London: Academic Press.
Sanger, D. J., Benavides, J., Perrault, G., Morel, E., Cohen, C., Joly, D., & Zivkovic, B. (1994). Recent developments in the behavioral pharmacology of benzodiazepine (w) receptors: Evidence for the functional significance of receptor subtypes.Neuroscience and Biobehavioral Reviews,18, 355–372.
Sannerud, C. A., Cook, J. M., & Griffiths, R. R. (1989). Behavioral differentiation of benzodiazepine ligands after repeated administration in baboons.European Journal of Pharmacology,167, 333–343.
Sassim, N., & Grohmann, R. (1988). Adverse drug reactions with clozapine and simultaneous application of benzodiazepines.Pharmacopsychiatry.21, 306–307.
Saunders, P A., & Ho, I. K. (1990). Barbiturates and the GABAA receptor complex.Progress in Drug Research,34, 261–286.
Scherkl, R., & Frey, H. (1986). Physical dependence on clonazepam in dogs.Pharmacology,32, 18–24.
Scheuler, W. (1990–1991). EEG sleep activities react topographically different to GABAergic sleep modulation by flunitrazepam: Relationship to regional distribution of benzodiazepine receptor subtypes?Neuropsychobiology,23, 213–221.
Schlumpf, M., Parmar, R., Ramseier, H. R., & Lichtensteiger, W. (1990). Prenatal benzodiazepine immunosuppression: Possible involvement of peripheral benzodiazepine site.Developmental Pharmacology Therapeutics,15, 178–185.
Schlumpf, M., Parmar, R., & Lichtensteiger, W. (1993). Prenatal diazepam induced persisting downregulation of peripheral (w3) benzodiazepine receptors on rat splenic macrophages.Life Sciences,52, 927–934.
Schlumpf, M., Lichtensteiger, W, & van Loveren, H. (1994). Impaired host resistance toTrichinella spiralisas a consequence of prenatal treatment of rats with diazepam.Toxicology,94, 223–230.
Schmidt, R. E, Vogel, M. E., & Zimmerman, M. (1967). Die wirkung von diazepam auf die präsynaptische hemmung and andere rückenmarksreflexe.NaunynSchmiedebergs Archives of Pharmacology,258, 69–82.
Schofield, P. R., Darlison, M. G., Fugita, N., Burt, D. R., Stephenson, F. A., Rodriguez, H., Rhee, L. M., Ramachandran, J., Reale, V., Glencorse, T. A., Seeburg, P. H., & Barnard, E. A. (1987). Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family.Nature(London).328, 221–227.
Shibuya, T., Watanabe, Y., Hill, H. E, & Salafsky, B. (1986). Developmental alterations in maturing rats caused by chronic prenatal and postnatal diazepam treatments.Japanese Journal of Pharmacology,40, 21–29.
Sieghart, W. (1995). Structure and pharmacology ofyaminobutyric acid, receptor subtypes.Pharmacological Reviews,47, 181–234.
Sloan, J. W., Martin, W. R., & Wala, E. P. (1990). Dependence-producing properties of alprazolam in the dog.Pharmacology,Biochemistry and Behavior,35, 651–657.
Sloan, J. W., Martin, W. R., & Wala, E. P. (1991a). A comparison of the physical dependence inducing properties of flunitrazepam and diazepam.Pharmacology,Biochemistry and Behavior,39, 395–405.
Sloan, J. W., Martin, W. R., & Wala, E. (1991b). Duration of diazepam (DZ) treatment and the intensity of flumazenil precipitated abstinence (FPA) in dogs [Abstracts].Federation of the American Society for Experimental Biology Journal, 3, Part I, A703.
Sloan, J. W., Martin, W. R., Wala, E., Dickey, K. M. (1991). Chronic administration of and dependence on halazepam, diazepam, and nordiazepam in the dog.Drug and Alcohol Dependence,28, 249–264.
Sloan, J. W., Martin, W. R., & Wala, E. (1993a). Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.Journal of Pharmacology and Experimental Therapeutics,265, 11–52.
Sloan, J. W, Martin, W. R., & Wala, E. P. (1993b). Effects of flumazenil (F) and DMSO vehicle (V) microinjected (MI) into 4 brain sites in diazepam (D) dependent rats [Abstracts].Pharmacologist,35, 132.
Sloan, J. W., Wala, E. P., & Jing, X. (1994). Comparison of the response of 4 hippocampal (H) sites in diazepam (DZ) dependent rats to flumazenil (F) microinjections.Society for Neuroscience Abstracts,20, 1604.
Sloan, J. W., Wala, E. P., Jing, X., Holtman, J., Jr., & Lee, E. (1994). Chronic graded doses of diazepam capsule implants alter rat liver function tests [Abstracts].Federation of the American Society for Experimental Biology Journal, 8(4), Part I, 381.
Sloan, J. W, Wala, E. P., & Jing, X. (1995a). Comparison of precipitated abstinence (PA) induced by focally injected flumazenil (FL) into different cerebellar (CB) loci in diazepam (DZ) dependent rats [Abstracts].Federation of the American Society for Experimental Biology Journal,9, A407.
Sloan, J. W, Wala, E. P., & Jing, X. (19956). The effect of intra-amygdaloid administration of flumazenil in diazepam-dependent rats.Society for Neuroscience Abstracts,21, 2098.
Sloan, J. W, Jing, X., Wala, E., & Milliken, B. (1996). The focal injection of flumazenil (FLU) into the CA, of hippocampus (Hi) of diazepam (DZ)-dependent rats produces a dose-related precipitated abstinence [Abstracts].Federation of the American Society for Experimental Biology Journal 10(3), A713.
Sloan, J. W, Wala, E. P, & Jing, X. (1997a). PK 11195 (PK)-evoked withdrawal in diazepam (DZ)-dependent rats: Effect of dose of PK, DZ and gender.Neuroscience Abstracts,23(2), 2392.
Sloan, J. W., Wala, E. P, & Jing, X. (1997b). The effect of focal injections of graded doses of flumazenil (FLU) and PK 11195 (PK) into the CAI of the hippocampus (HI) of diazepam (DZ)-dependent rats.Pharmacologist,39(1), 90.
Smith, C. M. (1992). Antianxiety drugs. In C. M. Smith, & A. M. Reynard, (Eds.),Textbook of pharmacology(pp. 271–297 ). Philadelphia: Saunders.
Speight, A. N. (1977). Floppy-infant syndrome and mater- nal diazepam and/or nitrazepam.Lancet,2, 878.
Spivey, W. H. (1992). Flumazenil and seizures: Analysis of 43cases. Clinical Therapeutics,14, 292–305.
Takeno, S., Hirano, Y., Kitamura, A., & Sakai, T. (1993). Comparative developmental toxicity and metabolism of nitrazepam in rats and mice.Toxicology Applied Pharmacology,121, 233–238.
Tedesco, F. J., & Mills, L. R. (1982). Diazepam (valium) hepatitis.Digestive Diseases and Sciences,27, 470–472.
Thomson, I., Fraser, R., & Kenyon, C. J. (1995). Regulation of adrenocortical steroidogenesis by benzodiazepines.Journal of Steroid Biochemistry and Molecular Biology,53, 75–79.
Tietz, E. I., Rosenberg, H. C., & Chiu, T. H. (1986). Autoradiographic localization of benzodiazepine receptor downregulation.Journal of Pharmacology and Experimental Therapeutics,236, 284–292.
Troisi, 1. 1., Jr., Critchfield, T. S., & Griffiths, R. R. (1993). Buspirone and lorazepam abuse liability in humans: Behavioral effects, subjective effects and choice.Behavioral Pharmacology,4, 217–230.
Tucker, J. C. (1985). Benzodiazepines and the developing rat: A critical review.Neuroscience and Biobehavioral Reviews,9, 101–111.
Urbancic, M., Gadek, M. A., & Marczynski, T. J. (1990). Chronic exposure to flumazenil: Anxiolytic effect and increased exploratory behavior.Pharmacology,Biochemistry and Behavior,35, 503–509.
Valerio, A., & Massotti, M. (1988). Electroencephalographic changes after short-term exposure to agonists of benzodiazepine receptors in the rat.Pharmacology,Biochemistry and Behavior,29, 791–795.
Verdoorn, T. A. (1994). Formation of heteromericyaminobutyric acid type A receptors containing two different a subunits.Molecular Pharmacology,45, 475–480.
Verdoorn, T. A., Draguhn, A., Ymer, S., Seeburg, P. H., & Sakmann, B. (1990). Functional properties of recombinant rat GABAA receptors depend upon subunit composition.Neuron,4, 919–928.
Wala, E. P., Sloan, J. W., & Jing, X. (1994). Intra-stratial administration of flumazenil (FL) to diazepam (DZ) dependent rats.Society for Neuroscience Abstracts 20, 1612.
Wala, E. P, Sloan, J. W., Martin, W. R., & Jing, X. (1994) Abstinence syndrome following focal administrations of flumazenil (FL) into the cerebellum (CB) and fourth ventricle (4V) in diazepam (DZ) dependent rats.Canadian Journal of Physiology and Pharmacology,Abstracts XII International Congress of Pharmacology(Vol. 72, Suppl. 1 ), 391.
Wala, E. P., Sloan, J. W, Jing, X., & Holtman, P. H. (1996). Intrathecally administed flumazenil and PK 11195 precipitate abstinence syndrome in diazepam dependent rats.Drug and Alcohol Dependence,43, 169–177.
Wala, E. P, Sloan, J. W., & Jing, X. (1997a). Dorsal raphe and substantia nigra response to flumazenil in diazepam-dependent rats.Pharmacology,Biochemistry and Behavior,58(1), 221–229.
Wala, E. P., Sloan, J. W., & Jing, X. (1997b). Comparison of abstinence syndromes precipitated by flumazenil and PK 11195 in female diazepam-dependent rats.Psychopharmacology,133(3), 214–223.
Wala, E. P., Sloan, J. W., & Jing, X. (1997c). Substantia nigra: The involvement of the central and peripheral benzodiazepine receptors in physical dependence on diazepam in rats.Society for Neuroscience Abstracts,231(2), 2401.
Weitzman, R., & Gavish, M. (1989). Chronic diazepam treatment induces an increase in peripheral benzodiazepine binding sites.Clinical Neuropharmacology,12, 346–351.
Weizman, R., Leschiner, S., Schlegel, W., & Gavish M. (1997). Peripheral-type benzodiazepine receptor ligands and serum steroid hormones.Brain Research,772, 203–308.
Whitehouse, B. J. (1992). Benzodiazepines and steroidogenesis.Journal of Endocrinology 134, 1 - 3.
Williams, M. (1984). Molecular aspects of the action of benzodiazepines and non-benzodiazepine anxiolytics: A hypothetical allosteric model of the benzodiazepine receptor complex.Progress in Neuro-Psychopharmacologv and Biological Psychiatry,8, 209–247.
Woods, J. H., Katz, J. L., & Winger, G. (1992). Benzodiazepines: Use, abuse, and consequences.Pharmacological Reviews,44, 151–347.
Yamadera, H., Kato, M., Ueno, T., Tsukahara, Y., & Okuma, T. (1993). Pharmaco-EEG mapping of diazepam effects using different references and absolute and relative power.Pharmacopsychiatry,26, 254–258.
Yanagita, T. (1981). Dependence-producing effects of anxiolytics. In F. Hoffmeister & G. Stille (Eds.),Psychotropic agents(pp. 395–406 ). Berlin: Springer-Verlag.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sloan, J.W., Wala, E.P. (1998). Pharmacology of Sedatives, Hypnotics, and Anxiolytics. In: Tarter, R.E., Ammerman, R.T., Ott, P.J. (eds) Handbook of Substance Abuse. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2913-9_27
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2913-9_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3297-6
Online ISBN: 978-1-4757-2913-9
eBook Packages: Springer Book Archive